Matrix tablet permitting the sustained release of indapamide after oral administration
US5334392A · kind A · utility
12Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 1992 |
| Grant date | Aug 2, 1994 |
| Priority date | — |
| Expiry date | Jun 9, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a matrix tablet for the sustained release of indapamide which ensures a continuous and uniform release of the active principle after oral administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.